Controlled Hypertension

Remote BP monitoring and collaborative telehealth visits with a pharmacist improved BP control among patients at rural nephrology clinics and reduced hospitalization, a speaker reported.

Winter-induced elevations in BP were persistent among patients with hypertension despite treatment with up to three classes of antihypertensive medications, with an approximately 7% drop in BP control, researchers reported.

A Kaiser Permanente Southern California quality improvement program reduced but did not entirely eliminate racial disparities in BP control between Black and white patients, researchers reported.

Electronic records from three large health care systems showed that the first 8 months of the COVID-19 pandemic were associated with worsening BP outcomes among people with hypertension across all socioeconomic backgrounds.

BP control declined among U.S. adults in 2020 compared with 2019, due to the COVID-19 pandemic, according to a study of 24 health systems presented at the American Heart Association Scientific Sessions.

Controlled hypertension was associated with higher risk for major adverse cardiac and cerebrovascular events and all-cause mortality compared with normotension, according to results published in Heart.

Interventions tailored to address specific socioeconomic concerns of patients with hypertension may lead to BP reduction and improved BP control, researchers reported at the virtual American Heart Association Scientific Sessions.

The number of BP readings performed by adults in a home BP management program and overall BP control were not impacted during the COVID-19 pandemic compared with data from 2019, according to new research.

Research presented at the virtual American Heart Association Hypertension Scientific Session showed that BP control dropped more than 11% in the United States from 2013 to 2018. It was the top story in cardiology last week.